EUVIMEDEUVIMED entdecken
Crossref

Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors

François-Xavier Mauvais, Yamina Hamel, Aymeric Silvin, Kevin Mulder, Kai Hildner, Ramazan Akyol, Marc Dalod, Despoina Koumantou, Loredana Saveanu, Meriem Garfa, Nicolas Cagnard, Barbara Bertocci und 2 weitere

Immunity · 2025

DOI: 10.1016/j.immuni.2025.02.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2025. Verfasst von François-Xavier Mauvais und 13 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, 75015 Paris, France; Service de Physiologie - Explorations Fonctionnelles Pédia…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Cross-Priming, Macrophages, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Agence nationale de la recherche, Fondation ARC pour la Recherche sur Le Cancer, Fondation Gustave Roussy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Splenic metallophilic marginal zone macrophages (MMMs) are positioned to control the dissemination of blood-borne threats. We developed a purification protocol to enable characterization of MMMs phenotypically and transcriptionally. MMM gene expression profile was enriched for pathways associated with CD8+ T cell activation and major histocompatibility complex class I (MHC class I) cross-presentation. In vitro, purified MMMs equaled conventional dendritic cells type 1 (cDC1s) in cross-priming CD8+ T cells to soluble and particulate antigens, yet MMMs employed a distinct vacuolar processing pathway. In vivo biphoton and ex vivo light-sheet imaging showed long-standing contacts with cognate T cells differentiating to effectors. MMMs cross-primed protective CD8+ T cell antitumor responses both by capturing blood-borne tumor antigens and by internalizing tumor cells seeding the spleen. This cross-priming required expression of the transcription factor Batf3 by MMMs but was independent of cDC1-mediated capture of tumor material for cross-presentation or MHC class I-dressing. Thus, MMMs combine control of the dissemination of blood-borne pathogens and tumor materials with the initiation of innate and adaptive responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesCross-PrimingMacrophagesNeoplasmsAnimalsMiceMice, Inbred C57BLHistocompatibility Antigens Class IAntigen PresentationSpleenDendritic CellsLymphocyte ActivationBasic-Leucine Zipper Transcription FactorsAntigens, NeoplasmRepressor Proteins

Stichwörter der Autor:innen

MHC class Iantigen cross-presentationcytotoxic T lymphocytesimmune responsemacrophagemarginal zonespleentumor responsevacuolar processing pathway

Substanzen

SNFT protein, mouseHistocompatibility Antigens Class IBasic-Leucine Zipper Transcription FactorsAntigens, NeoplasmRepressor Proteins

Autor:innen und Institutionen

  • Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, 75015 Paris, France; Service de Physiologie - Explorations Fonctionnelles Pédiatriques, AP-HP, Hôpital Universitaire Robert Debré, 75019 Paris, Franc…
  • Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, 75015 Paris, France.
  • Gustave Roussy Cancer Campus, Villejuif, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
  • University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Medical Department 1, Deutsches Zentrum Immuntherapie, 91054 Erlangen, Germany.
  • Aix Marseille Université, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Turing Center for Living Systems, Marseille, France.
  • Université Paris Cité, Centre de recherche sur l'inflammation, INSERM UMR1149, CNRS EMR8252, Faculté de Médecine site Bichat, 75018 Paris, France; Université Paris Cité, Laboratoire d'Excellence Inflamex, 75018 Paris, F…

Förderung

  • Agence nationale de la recherche
  • Fondation ARC pour la Recherche sur Le Cancer
  • Fondation Gustave Roussy
  • Fondation pour la Recherche Médicale
  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Mauvais, F. X., Hamel, Y., Silvin, A., Mulder, K., Hildner, K., Akyol, R., Dalod, M., Koumantou, D., Saveanu, L., Garfa, M., Cagnard, N., Bertocci, B., Ginhoux, F., & van Endert, P. (2025). Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors. Immunity. https://doi.org/10.1016/j.immuni.2025.02.027

Vancouver

Mauvais FX, Hamel Y, Silvin A, Mulder K, Hildner K, Akyol R, et al. Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors. Immunity. 2025. doi:10.1016/j.immuni.2025.02.027

BibTeX
@article{Mauvais2025,
  author = {Mauvais, François-Xavier and Hamel, Yamina and Silvin, Aymeric and Mulder, Kevin and Hildner, Kai and Akyol, Ramazan and Dalod, Marc and Koumantou, Despoina and Saveanu, Loredana and Garfa, Meriem and Cagnard, Nicolas and Bertocci, Barbara and Ginhoux, Florent and van Endert, Peter},
  title = {Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors},
  journal = {Immunity},
  year = {2025},
  doi = {10.1016/j.immuni.2025.02.027}
}
Kostenlos starten →